Global Lipid Nanoparticle (LNP) CDMO Service Supply, Demand and Key Producers, 2026-2032
The global Lipid Nanoparticle (LNP) CDMO Service market size is expected to reach $ 1771 million by 2032, rising at a market growth of 13.7% CAGR during the forecast period (2026-2032).
Lipid Nanoparticle (LNP) CDMO Service refers to a specialized contract research and manufacturing service dedicated to supporting biopharmaceutical companies, biotech startups, and research institutions in the full lifecycle development and production of lipid nanoparticles— the gold-standard delivery vehicles for nucleic acid therapeutics including mRNA vaccines, siRNA gene silencing therapies, and CRISPR-based gene editing platforms.
Lipid Nanoparticle (LNP) CDMO Service is developing rapidly as RNA-based drugs, mRNA vaccines, siRNA therapies, gene-editing delivery systems and personalized cancer immunotherapies move from early R&D toward clinical and commercial manufacturing; key industry trends include outsourcing of LNP formulation, process development, analytical characterization, GMP scale-up, sterile fill-finish integration, and platform-based lipid formulation technologies. Market opportunities mainly come from biotech companies that lack in-house LNP formulation know-how, the expansion of non-vaccine mRNA therapeutics, demand for targeted delivery systems, and regional capacity building in the US, Europe and China. However, the industry also faces challenges such as high technical barriers in ionizable lipid selection, particle size control, encapsulation efficiency, stability testing, batch-to-batch consistency, raw material quality, GMP compliance, IP restrictions around lipid formulations, high production cost, and limited experienced CDMO capacity. Recent market estimates generally show double-digit growth expectations for LNP CDMO services, driven by RNA therapeutics and advanced drug-delivery demand.
This report studies the global Lipid Nanoparticle (LNP) CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lipid Nanoparticle (LNP) CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lipid Nanoparticle (LNP) CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lipid Nanoparticle (LNP) CDMO Service total market, 2021-2032, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lipid Nanoparticle (LNP) CDMO Service total market, key domestic companies, and share, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lipid Nanoparticle (LNP) CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Evonik, Patheon, CordenPharma, FUJIFILM Holdings, WuXi STA, Nippon Fine Chemical, Croda International, ProBio, Polymun Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lipid Nanoparticle (LNP) CDMO Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lipid Nanoparticle (LNP) CDMO Service Market, By Region:
1. How big is the global Lipid Nanoparticle (LNP) CDMO Service market?
2. What is the demand of the global Lipid Nanoparticle (LNP) CDMO Service market?
3. What is the year over year growth of the global Lipid Nanoparticle (LNP) CDMO Service market?
4. What is the total value of the global Lipid Nanoparticle (LNP) CDMO Service market?
5. Who are the Major Players in the global Lipid Nanoparticle (LNP) CDMO Service market?
6. What are the growth factors driving the market demand?
Lipid Nanoparticle (LNP) CDMO Service refers to a specialized contract research and manufacturing service dedicated to supporting biopharmaceutical companies, biotech startups, and research institutions in the full lifecycle development and production of lipid nanoparticles— the gold-standard delivery vehicles for nucleic acid therapeutics including mRNA vaccines, siRNA gene silencing therapies, and CRISPR-based gene editing platforms.
Lipid Nanoparticle (LNP) CDMO Service is developing rapidly as RNA-based drugs, mRNA vaccines, siRNA therapies, gene-editing delivery systems and personalized cancer immunotherapies move from early R&D toward clinical and commercial manufacturing; key industry trends include outsourcing of LNP formulation, process development, analytical characterization, GMP scale-up, sterile fill-finish integration, and platform-based lipid formulation technologies. Market opportunities mainly come from biotech companies that lack in-house LNP formulation know-how, the expansion of non-vaccine mRNA therapeutics, demand for targeted delivery systems, and regional capacity building in the US, Europe and China. However, the industry also faces challenges such as high technical barriers in ionizable lipid selection, particle size control, encapsulation efficiency, stability testing, batch-to-batch consistency, raw material quality, GMP compliance, IP restrictions around lipid formulations, high production cost, and limited experienced CDMO capacity. Recent market estimates generally show double-digit growth expectations for LNP CDMO services, driven by RNA therapeutics and advanced drug-delivery demand.
This report studies the global Lipid Nanoparticle (LNP) CDMO Service demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Lipid Nanoparticle (LNP) CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Lipid Nanoparticle (LNP) CDMO Service that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Lipid Nanoparticle (LNP) CDMO Service total market, 2021-2032, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Lipid Nanoparticle (LNP) CDMO Service total market, key domestic companies, and share, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service revenue by player, revenue and market share 2021-2026, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by Type, CAGR, 2021-2032, (USD Million)
Global Lipid Nanoparticle (LNP) CDMO Service total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Lipid Nanoparticle (LNP) CDMO Service market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Evonik, Patheon, CordenPharma, FUJIFILM Holdings, WuXi STA, Nippon Fine Chemical, Croda International, ProBio, Polymun Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Lipid Nanoparticle (LNP) CDMO Service market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Lipid Nanoparticle (LNP) CDMO Service Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Formulation Development
- cGMP Manufacturing
- Others
- mRNA-LNP CDMO Service
- siRNA-LNP CDMO Service
- Others
- Small-Scale Type: <1 L
- Pilot / Clinical Type: 1–50 L
- Commercial-Scale Type: >50 L
- Vaccine Development
- Gene Therapy
- Drug Delivery
- Others
- Merck
- Evonik
- Patheon
- CordenPharma
- FUJIFILM Holdings
- WuXi STA
- Nippon Fine Chemical
- Croda International
- ProBio
- Polymun Scientific
- Helix Biotech
- Catalent
- Porton Advanced
- CATUG
- Samsung Biologics
- Biomay
- Pace Analytical
- Vernal Biosciences
- Lonza
- Acuitas Therapeutics
- Creative Biolabs
- Curapath
- phosphorex
- QiyueBio
1. How big is the global Lipid Nanoparticle (LNP) CDMO Service market?
2. What is the demand of the global Lipid Nanoparticle (LNP) CDMO Service market?
3. What is the year over year growth of the global Lipid Nanoparticle (LNP) CDMO Service market?
4. What is the total value of the global Lipid Nanoparticle (LNP) CDMO Service market?
5. Who are the Major Players in the global Lipid Nanoparticle (LNP) CDMO Service market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Lipid Nanoparticle (LNP) CDMO Service Introduction
1.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lipid Nanoparticle (LNP) CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.3 China Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.4 Europe Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.5 Japan Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.6 South Korea Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.8 India Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lipid Nanoparticle (LNP) CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.2 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region
2.2.1 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region (2021-2026)
2.2.2 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.4 China Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.5 Europe Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.6 Japan Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.7 South Korea Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.8 ASEAN Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.9 India Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
3 WORLD LIPID NANOPARTICLE (LNP) CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lipid Nanoparticle (LNP) CDMO Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lipid Nanoparticle (LNP) CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lipid Nanoparticle (LNP) CDMO Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Lipid Nanoparticle (LNP) CDMO Service in 2025
3.3 Lipid Nanoparticle (LNP) CDMO Service Company Evaluation Quadrant
3.4 Lipid Nanoparticle (LNP) CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Lipid Nanoparticle (LNP) CDMO Service Market: Region Footprint
3.4.2 Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Type Footprint
3.4.3 Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lipid Nanoparticle (LNP) CDMO Service Companies and Market Share, 2021-2026
4.3.1 United States Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026)
4.4 China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue and Market Share, 2021-2026
4.4.1 China Based Lipid Nanoparticle (LNP) CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026)
4.5 Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Formulation Development
5.2.2 cGMP Manufacturing
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2021-2026)
5.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2027-2032)
5.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY NUCLEIC ACID TYPE
6.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Nucleic Acid Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Nucleic Acid Type
6.2.1 mRNA-LNP CDMO Service
6.2.2 siRNA-LNP CDMO Service
6.2.3 Others
6.3 Market Segment by Nucleic Acid Type
6.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2021-2026)
6.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2027-2032)
6.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type (2027-2032)
7 MARKET ANALYSIS BY BATCH SCALE
7.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Batch Scale
7.2.1 Small-Scale Type: <1 L
7.2.2 Pilot / Clinical Type: 1–50 L
7.2.3 Commercial-Scale Type: >50 L
7.3 Market Segment by Batch Scale
7.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2021-2026)
7.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2027-2032)
7.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Vaccine Development
8.2.2 Gene Therapy
8.2.3 Drug Delivery
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021-2026)
8.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2027-2032)
8.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck
9.1.1 Merck Details
9.1.2 Merck Major Business
9.1.3 Merck Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.1.4 Merck Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Recent Developments/Updates
9.1.6 Merck Competitive Strengths & Weaknesses
9.2 Evonik
9.2.1 Evonik Details
9.2.2 Evonik Major Business
9.2.3 Evonik Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.2.4 Evonik Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Evonik Recent Developments/Updates
9.2.6 Evonik Competitive Strengths & Weaknesses
9.3 Patheon
9.3.1 Patheon Details
9.3.2 Patheon Major Business
9.3.3 Patheon Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.3.4 Patheon Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Patheon Recent Developments/Updates
9.3.6 Patheon Competitive Strengths & Weaknesses
9.4 CordenPharma
9.4.1 CordenPharma Details
9.4.2 CordenPharma Major Business
9.4.3 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.4.4 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CordenPharma Recent Developments/Updates
9.4.6 CordenPharma Competitive Strengths & Weaknesses
9.5 FUJIFILM Holdings
9.5.1 FUJIFILM Holdings Details
9.5.2 FUJIFILM Holdings Major Business
9.5.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.5.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 FUJIFILM Holdings Recent Developments/Updates
9.5.6 FUJIFILM Holdings Competitive Strengths & Weaknesses
9.6 WuXi STA
9.6.1 WuXi STA Details
9.6.2 WuXi STA Major Business
9.6.3 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.6.4 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 WuXi STA Recent Developments/Updates
9.6.6 WuXi STA Competitive Strengths & Weaknesses
9.7 Nippon Fine Chemical
9.7.1 Nippon Fine Chemical Details
9.7.2 Nippon Fine Chemical Major Business
9.7.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.7.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nippon Fine Chemical Recent Developments/Updates
9.7.6 Nippon Fine Chemical Competitive Strengths & Weaknesses
9.8 Croda International
9.8.1 Croda International Details
9.8.2 Croda International Major Business
9.8.3 Croda International Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.8.4 Croda International Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Croda International Recent Developments/Updates
9.8.6 Croda International Competitive Strengths & Weaknesses
9.9 ProBio
9.9.1 ProBio Details
9.9.2 ProBio Major Business
9.9.3 ProBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.9.4 ProBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ProBio Recent Developments/Updates
9.9.6 ProBio Competitive Strengths & Weaknesses
9.10 Polymun Scientific
9.10.1 Polymun Scientific Details
9.10.2 Polymun Scientific Major Business
9.10.3 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.10.4 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Polymun Scientific Recent Developments/Updates
9.10.6 Polymun Scientific Competitive Strengths & Weaknesses
9.11 Helix Biotech
9.11.1 Helix Biotech Details
9.11.2 Helix Biotech Major Business
9.11.3 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.11.4 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Helix Biotech Recent Developments/Updates
9.11.6 Helix Biotech Competitive Strengths & Weaknesses
9.12 Catalent
9.12.1 Catalent Details
9.12.2 Catalent Major Business
9.12.3 Catalent Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.12.4 Catalent Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Catalent Recent Developments/Updates
9.12.6 Catalent Competitive Strengths & Weaknesses
9.13 Porton Advanced
9.13.1 Porton Advanced Details
9.13.2 Porton Advanced Major Business
9.13.3 Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.13.4 Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Porton Advanced Recent Developments/Updates
9.13.6 Porton Advanced Competitive Strengths & Weaknesses
9.14 CATUG
9.14.1 CATUG Details
9.14.2 CATUG Major Business
9.14.3 CATUG Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.14.4 CATUG Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CATUG Recent Developments/Updates
9.14.6 CATUG Competitive Strengths & Weaknesses
9.15 Samsung Biologics
9.15.1 Samsung Biologics Details
9.15.2 Samsung Biologics Major Business
9.15.3 Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.15.4 Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Samsung Biologics Recent Developments/Updates
9.15.6 Samsung Biologics Competitive Strengths & Weaknesses
9.16 Biomay
9.16.1 Biomay Details
9.16.2 Biomay Major Business
9.16.3 Biomay Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.16.4 Biomay Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Biomay Recent Developments/Updates
9.16.6 Biomay Competitive Strengths & Weaknesses
9.17 Pace Analytical
9.17.1 Pace Analytical Details
9.17.2 Pace Analytical Major Business
9.17.3 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.17.4 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Pace Analytical Recent Developments/Updates
9.17.6 Pace Analytical Competitive Strengths & Weaknesses
9.18 Vernal Biosciences
9.18.1 Vernal Biosciences Details
9.18.2 Vernal Biosciences Major Business
9.18.3 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.18.4 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Vernal Biosciences Recent Developments/Updates
9.18.6 Vernal Biosciences Competitive Strengths & Weaknesses
9.19 Lonza
9.19.1 Lonza Details
9.19.2 Lonza Major Business
9.19.3 Lonza Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.19.4 Lonza Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Lonza Recent Developments/Updates
9.19.6 Lonza Competitive Strengths & Weaknesses
9.20 Acuitas Therapeutics
9.20.1 Acuitas Therapeutics Details
9.20.2 Acuitas Therapeutics Major Business
9.20.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.20.4 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Acuitas Therapeutics Recent Developments/Updates
9.20.6 Acuitas Therapeutics Competitive Strengths & Weaknesses
9.21 Creative Biolabs
9.21.1 Creative Biolabs Details
9.21.2 Creative Biolabs Major Business
9.21.3 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.21.4 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Creative Biolabs Recent Developments/Updates
9.21.6 Creative Biolabs Competitive Strengths & Weaknesses
9.22 Curapath
9.22.1 Curapath Details
9.22.2 Curapath Major Business
9.22.3 Curapath Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.22.4 Curapath Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Curapath Recent Developments/Updates
9.22.6 Curapath Competitive Strengths & Weaknesses
9.23 phosphorex
9.23.1 phosphorex Details
9.23.2 phosphorex Major Business
9.23.3 phosphorex Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.23.4 phosphorex Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 phosphorex Recent Developments/Updates
9.23.6 phosphorex Competitive Strengths & Weaknesses
9.24 QiyueBio
9.24.1 QiyueBio Details
9.24.2 QiyueBio Major Business
9.24.3 QiyueBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.24.4 QiyueBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 QiyueBio Recent Developments/Updates
9.24.6 QiyueBio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lipid Nanoparticle (LNP) CDMO Service Industry Chain
10.2 Lipid Nanoparticle (LNP) CDMO Service Upstream Analysis
10.3 Lipid Nanoparticle (LNP) CDMO Service Midstream Analysis
10.4 Lipid Nanoparticle (LNP) CDMO Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Lipid Nanoparticle (LNP) CDMO Service Introduction
1.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Lipid Nanoparticle (LNP) CDMO Service Total Market by Region (by Headquarter Location)
1.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.3 China Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.4 Europe Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.5 Japan Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.6 South Korea Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.7 ASEAN Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.3.8 India Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Lipid Nanoparticle (LNP) CDMO Service Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.2 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region
2.2.1 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region (2021-2026)
2.2.2 World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Forecast by Region (2027-2032)
2.3 United States Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.4 China Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.5 Europe Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.6 Japan Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.7 South Korea Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.8 ASEAN Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
2.9 India Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032)
3 WORLD LIPID NANOPARTICLE (LNP) CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS
3.1 World Lipid Nanoparticle (LNP) CDMO Service Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Lipid Nanoparticle (LNP) CDMO Service Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Lipid Nanoparticle (LNP) CDMO Service in 2025
3.2.3 Global Concentration Ratios (CR8) for Lipid Nanoparticle (LNP) CDMO Service in 2025
3.3 Lipid Nanoparticle (LNP) CDMO Service Company Evaluation Quadrant
3.4 Lipid Nanoparticle (LNP) CDMO Service Market: Overall Company Footprint Analysis
3.4.1 Lipid Nanoparticle (LNP) CDMO Service Market: Region Footprint
3.4.2 Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Type Footprint
3.4.3 Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison
4.2.1 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Lipid Nanoparticle (LNP) CDMO Service Companies and Market Share, 2021-2026
4.3.1 United States Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026)
4.4 China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue and Market Share, 2021-2026
4.4.1 China Based Lipid Nanoparticle (LNP) CDMO Service Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026)
4.5 Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Formulation Development
5.2.2 cGMP Manufacturing
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2021-2026)
5.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2027-2032)
5.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY NUCLEIC ACID TYPE
6.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Nucleic Acid Type: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Nucleic Acid Type
6.2.1 mRNA-LNP CDMO Service
6.2.2 siRNA-LNP CDMO Service
6.2.3 Others
6.3 Market Segment by Nucleic Acid Type
6.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2021-2026)
6.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2027-2032)
6.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type (2027-2032)
7 MARKET ANALYSIS BY BATCH SCALE
7.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Batch Scale: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Batch Scale
7.2.1 Small-Scale Type: <1 L
7.2.2 Pilot / Clinical Type: 1–50 L
7.2.3 Commercial-Scale Type: >50 L
7.3 Market Segment by Batch Scale
7.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2021-2026)
7.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2027-2032)
7.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Vaccine Development
8.2.2 Gene Therapy
8.2.3 Drug Delivery
8.2.4 Others
8.3 Market Segment by Application
8.3.1 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021-2026)
8.3.2 World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2027-2032)
8.3.3 World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Merck
9.1.1 Merck Details
9.1.2 Merck Major Business
9.1.3 Merck Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.1.4 Merck Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Merck Recent Developments/Updates
9.1.6 Merck Competitive Strengths & Weaknesses
9.2 Evonik
9.2.1 Evonik Details
9.2.2 Evonik Major Business
9.2.3 Evonik Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.2.4 Evonik Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Evonik Recent Developments/Updates
9.2.6 Evonik Competitive Strengths & Weaknesses
9.3 Patheon
9.3.1 Patheon Details
9.3.2 Patheon Major Business
9.3.3 Patheon Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.3.4 Patheon Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Patheon Recent Developments/Updates
9.3.6 Patheon Competitive Strengths & Weaknesses
9.4 CordenPharma
9.4.1 CordenPharma Details
9.4.2 CordenPharma Major Business
9.4.3 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.4.4 CordenPharma Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 CordenPharma Recent Developments/Updates
9.4.6 CordenPharma Competitive Strengths & Weaknesses
9.5 FUJIFILM Holdings
9.5.1 FUJIFILM Holdings Details
9.5.2 FUJIFILM Holdings Major Business
9.5.3 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.5.4 FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 FUJIFILM Holdings Recent Developments/Updates
9.5.6 FUJIFILM Holdings Competitive Strengths & Weaknesses
9.6 WuXi STA
9.6.1 WuXi STA Details
9.6.2 WuXi STA Major Business
9.6.3 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.6.4 WuXi STA Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 WuXi STA Recent Developments/Updates
9.6.6 WuXi STA Competitive Strengths & Weaknesses
9.7 Nippon Fine Chemical
9.7.1 Nippon Fine Chemical Details
9.7.2 Nippon Fine Chemical Major Business
9.7.3 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.7.4 Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Nippon Fine Chemical Recent Developments/Updates
9.7.6 Nippon Fine Chemical Competitive Strengths & Weaknesses
9.8 Croda International
9.8.1 Croda International Details
9.8.2 Croda International Major Business
9.8.3 Croda International Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.8.4 Croda International Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Croda International Recent Developments/Updates
9.8.6 Croda International Competitive Strengths & Weaknesses
9.9 ProBio
9.9.1 ProBio Details
9.9.2 ProBio Major Business
9.9.3 ProBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.9.4 ProBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 ProBio Recent Developments/Updates
9.9.6 ProBio Competitive Strengths & Weaknesses
9.10 Polymun Scientific
9.10.1 Polymun Scientific Details
9.10.2 Polymun Scientific Major Business
9.10.3 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.10.4 Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Polymun Scientific Recent Developments/Updates
9.10.6 Polymun Scientific Competitive Strengths & Weaknesses
9.11 Helix Biotech
9.11.1 Helix Biotech Details
9.11.2 Helix Biotech Major Business
9.11.3 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.11.4 Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 Helix Biotech Recent Developments/Updates
9.11.6 Helix Biotech Competitive Strengths & Weaknesses
9.12 Catalent
9.12.1 Catalent Details
9.12.2 Catalent Major Business
9.12.3 Catalent Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.12.4 Catalent Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Catalent Recent Developments/Updates
9.12.6 Catalent Competitive Strengths & Weaknesses
9.13 Porton Advanced
9.13.1 Porton Advanced Details
9.13.2 Porton Advanced Major Business
9.13.3 Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.13.4 Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Porton Advanced Recent Developments/Updates
9.13.6 Porton Advanced Competitive Strengths & Weaknesses
9.14 CATUG
9.14.1 CATUG Details
9.14.2 CATUG Major Business
9.14.3 CATUG Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.14.4 CATUG Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 CATUG Recent Developments/Updates
9.14.6 CATUG Competitive Strengths & Weaknesses
9.15 Samsung Biologics
9.15.1 Samsung Biologics Details
9.15.2 Samsung Biologics Major Business
9.15.3 Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.15.4 Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Samsung Biologics Recent Developments/Updates
9.15.6 Samsung Biologics Competitive Strengths & Weaknesses
9.16 Biomay
9.16.1 Biomay Details
9.16.2 Biomay Major Business
9.16.3 Biomay Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.16.4 Biomay Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.16.5 Biomay Recent Developments/Updates
9.16.6 Biomay Competitive Strengths & Weaknesses
9.17 Pace Analytical
9.17.1 Pace Analytical Details
9.17.2 Pace Analytical Major Business
9.17.3 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.17.4 Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.17.5 Pace Analytical Recent Developments/Updates
9.17.6 Pace Analytical Competitive Strengths & Weaknesses
9.18 Vernal Biosciences
9.18.1 Vernal Biosciences Details
9.18.2 Vernal Biosciences Major Business
9.18.3 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.18.4 Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.18.5 Vernal Biosciences Recent Developments/Updates
9.18.6 Vernal Biosciences Competitive Strengths & Weaknesses
9.19 Lonza
9.19.1 Lonza Details
9.19.2 Lonza Major Business
9.19.3 Lonza Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.19.4 Lonza Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.19.5 Lonza Recent Developments/Updates
9.19.6 Lonza Competitive Strengths & Weaknesses
9.20 Acuitas Therapeutics
9.20.1 Acuitas Therapeutics Details
9.20.2 Acuitas Therapeutics Major Business
9.20.3 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.20.4 Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.20.5 Acuitas Therapeutics Recent Developments/Updates
9.20.6 Acuitas Therapeutics Competitive Strengths & Weaknesses
9.21 Creative Biolabs
9.21.1 Creative Biolabs Details
9.21.2 Creative Biolabs Major Business
9.21.3 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.21.4 Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.21.5 Creative Biolabs Recent Developments/Updates
9.21.6 Creative Biolabs Competitive Strengths & Weaknesses
9.22 Curapath
9.22.1 Curapath Details
9.22.2 Curapath Major Business
9.22.3 Curapath Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.22.4 Curapath Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.22.5 Curapath Recent Developments/Updates
9.22.6 Curapath Competitive Strengths & Weaknesses
9.23 phosphorex
9.23.1 phosphorex Details
9.23.2 phosphorex Major Business
9.23.3 phosphorex Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.23.4 phosphorex Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.23.5 phosphorex Recent Developments/Updates
9.23.6 phosphorex Competitive Strengths & Weaknesses
9.24 QiyueBio
9.24.1 QiyueBio Details
9.24.2 QiyueBio Major Business
9.24.3 QiyueBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
9.24.4 QiyueBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026)
9.24.5 QiyueBio Recent Developments/Updates
9.24.6 QiyueBio Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Lipid Nanoparticle (LNP) CDMO Service Industry Chain
10.2 Lipid Nanoparticle (LNP) CDMO Service Upstream Analysis
10.3 Lipid Nanoparticle (LNP) CDMO Service Midstream Analysis
10.4 Lipid Nanoparticle (LNP) CDMO Service Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lipid Nanoparticle (LNP) CDMO Service Players in 2025
Table 12. World Lipid Nanoparticle (LNP) CDMO Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lipid Nanoparticle (LNP) CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Lipid Nanoparticle (LNP) CDMO Service Players
Table 15. Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Type Footprint
Table 16. Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Application Footprint
Table 17. Lipid Nanoparticle (LNP) CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 23. China Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 29. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Nucleic Acid Type (2021-2026) & (USD Million)
Table 34. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2027-2032) & (USD Million)
Table 35. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 36. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 37. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 38. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Merck Basic Information, Manufacturing Base and Competitors
Table 42. Merck Major Business
Table 43. Merck Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 44. Merck Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Merck Recent Developments/Updates
Table 46. Merck Competitive Strengths & Weaknesses
Table 47. Evonik Basic Information, Manufacturing Base and Competitors
Table 48. Evonik Major Business
Table 49. Evonik Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 50. Evonik Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Evonik Recent Developments/Updates
Table 52. Evonik Competitive Strengths & Weaknesses
Table 53. Patheon Basic Information, Manufacturing Base and Competitors
Table 54. Patheon Major Business
Table 55. Patheon Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 56. Patheon Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Patheon Recent Developments/Updates
Table 58. Patheon Competitive Strengths & Weaknesses
Table 59. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 60. CordenPharma Major Business
Table 61. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 62. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CordenPharma Recent Developments/Updates
Table 64. CordenPharma Competitive Strengths & Weaknesses
Table 65. FUJIFILM Holdings Basic Information, Manufacturing Base and Competitors
Table 66. FUJIFILM Holdings Major Business
Table 67. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 68. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. FUJIFILM Holdings Recent Developments/Updates
Table 70. FUJIFILM Holdings Competitive Strengths & Weaknesses
Table 71. WuXi STA Basic Information, Manufacturing Base and Competitors
Table 72. WuXi STA Major Business
Table 73. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 74. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. WuXi STA Recent Developments/Updates
Table 76. WuXi STA Competitive Strengths & Weaknesses
Table 77. Nippon Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 78. Nippon Fine Chemical Major Business
Table 79. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 80. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nippon Fine Chemical Recent Developments/Updates
Table 82. Nippon Fine Chemical Competitive Strengths & Weaknesses
Table 83. Croda International Basic Information, Manufacturing Base and Competitors
Table 84. Croda International Major Business
Table 85. Croda International Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 86. Croda International Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Croda International Recent Developments/Updates
Table 88. Croda International Competitive Strengths & Weaknesses
Table 89. ProBio Basic Information, Manufacturing Base and Competitors
Table 90. ProBio Major Business
Table 91. ProBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 92. ProBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ProBio Recent Developments/Updates
Table 94. ProBio Competitive Strengths & Weaknesses
Table 95. Polymun Scientific Basic Information, Manufacturing Base and Competitors
Table 96. Polymun Scientific Major Business
Table 97. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 98. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Polymun Scientific Recent Developments/Updates
Table 100. Polymun Scientific Competitive Strengths & Weaknesses
Table 101. Helix Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Helix Biotech Major Business
Table 103. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 104. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Helix Biotech Recent Developments/Updates
Table 106. Helix Biotech Competitive Strengths & Weaknesses
Table 107. Catalent Basic Information, Manufacturing Base and Competitors
Table 108. Catalent Major Business
Table 109. Catalent Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 110. Catalent Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Catalent Recent Developments/Updates
Table 112. Catalent Competitive Strengths & Weaknesses
Table 113. Porton Advanced Basic Information, Manufacturing Base and Competitors
Table 114. Porton Advanced Major Business
Table 115. Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 116. Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Porton Advanced Recent Developments/Updates
Table 118. Porton Advanced Competitive Strengths & Weaknesses
Table 119. CATUG Basic Information, Manufacturing Base and Competitors
Table 120. CATUG Major Business
Table 121. CATUG Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 122. CATUG Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CATUG Recent Developments/Updates
Table 124. CATUG Competitive Strengths & Weaknesses
Table 125. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 126. Samsung Biologics Major Business
Table 127. Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 128. Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Samsung Biologics Recent Developments/Updates
Table 130. Samsung Biologics Competitive Strengths & Weaknesses
Table 131. Biomay Basic Information, Manufacturing Base and Competitors
Table 132. Biomay Major Business
Table 133. Biomay Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 134. Biomay Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Biomay Recent Developments/Updates
Table 136. Biomay Competitive Strengths & Weaknesses
Table 137. Pace Analytical Basic Information, Manufacturing Base and Competitors
Table 138. Pace Analytical Major Business
Table 139. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 140. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Pace Analytical Recent Developments/Updates
Table 142. Pace Analytical Competitive Strengths & Weaknesses
Table 143. Vernal Biosciences Basic Information, Manufacturing Base and Competitors
Table 144. Vernal Biosciences Major Business
Table 145. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 146. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Vernal Biosciences Recent Developments/Updates
Table 148. Vernal Biosciences Competitive Strengths & Weaknesses
Table 149. Lonza Basic Information, Manufacturing Base and Competitors
Table 150. Lonza Major Business
Table 151. Lonza Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 152. Lonza Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Lonza Recent Developments/Updates
Table 154. Lonza Competitive Strengths & Weaknesses
Table 155. Acuitas Therapeutics Basic Information, Manufacturing Base and Competitors
Table 156. Acuitas Therapeutics Major Business
Table 157. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 158. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Acuitas Therapeutics Recent Developments/Updates
Table 160. Acuitas Therapeutics Competitive Strengths & Weaknesses
Table 161. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 162. Creative Biolabs Major Business
Table 163. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 164. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Creative Biolabs Recent Developments/Updates
Table 166. Creative Biolabs Competitive Strengths & Weaknesses
Table 167. Curapath Basic Information, Manufacturing Base and Competitors
Table 168. Curapath Major Business
Table 169. Curapath Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 170. Curapath Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Curapath Recent Developments/Updates
Table 172. Curapath Competitive Strengths & Weaknesses
Table 173. phosphorex Basic Information, Manufacturing Base and Competitors
Table 174. phosphorex Major Business
Table 175. phosphorex Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 176. phosphorex Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. phosphorex Recent Developments/Updates
Table 178. phosphorex Competitive Strengths & Weaknesses
Table 179. QiyueBio Basic Information, Manufacturing Base and Competitors
Table 180. QiyueBio Major Business
Table 181. QiyueBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 182. QiyueBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. QiyueBio Recent Developments/Updates
Table 184. QiyueBio Competitive Strengths & Weaknesses
Table 185. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service Upstream (Raw Materials)
Table 186. Global Lipid Nanoparticle (LNP) CDMO Service Typical Customers
Table 1. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Lipid Nanoparticle (LNP) CDMO Service Players in 2025
Table 12. World Lipid Nanoparticle (LNP) CDMO Service Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Lipid Nanoparticle (LNP) CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Lipid Nanoparticle (LNP) CDMO Service Players
Table 15. Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Type Footprint
Table 16. Lipid Nanoparticle (LNP) CDMO Service Market: Company Product Application Footprint
Table 17. Lipid Nanoparticle (LNP) CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Lipid Nanoparticle (LNP) CDMO Service Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Lipid Nanoparticle (LNP) CDMO Service Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 23. China Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 26. Rest of World Based Lipid Nanoparticle (LNP) CDMO Service Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share (2021-2026)
Table 29. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type (2027-2032) & (USD Million)
Table 32. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type, (USD Million), 2021 & 2025 & 2032
Table 33. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Nucleic Acid Type (2021-2026) & (USD Million)
Table 34. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type (2027-2032) & (USD Million)
Table 35. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Table 36. World Lipid Nanoparticle (LNP) CDMO Service Market Size Value by Batch Scale (2021-2026) & (USD Million)
Table 37. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale (2027-2032) & (USD Million)
Table 38. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2021-2026) & (USD Million)
Table 40. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application (2027-2032) & (USD Million)
Table 41. Merck Basic Information, Manufacturing Base and Competitors
Table 42. Merck Major Business
Table 43. Merck Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 44. Merck Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Merck Recent Developments/Updates
Table 46. Merck Competitive Strengths & Weaknesses
Table 47. Evonik Basic Information, Manufacturing Base and Competitors
Table 48. Evonik Major Business
Table 49. Evonik Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 50. Evonik Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Evonik Recent Developments/Updates
Table 52. Evonik Competitive Strengths & Weaknesses
Table 53. Patheon Basic Information, Manufacturing Base and Competitors
Table 54. Patheon Major Business
Table 55. Patheon Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 56. Patheon Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Patheon Recent Developments/Updates
Table 58. Patheon Competitive Strengths & Weaknesses
Table 59. CordenPharma Basic Information, Manufacturing Base and Competitors
Table 60. CordenPharma Major Business
Table 61. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 62. CordenPharma Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CordenPharma Recent Developments/Updates
Table 64. CordenPharma Competitive Strengths & Weaknesses
Table 65. FUJIFILM Holdings Basic Information, Manufacturing Base and Competitors
Table 66. FUJIFILM Holdings Major Business
Table 67. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 68. FUJIFILM Holdings Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. FUJIFILM Holdings Recent Developments/Updates
Table 70. FUJIFILM Holdings Competitive Strengths & Weaknesses
Table 71. WuXi STA Basic Information, Manufacturing Base and Competitors
Table 72. WuXi STA Major Business
Table 73. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 74. WuXi STA Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. WuXi STA Recent Developments/Updates
Table 76. WuXi STA Competitive Strengths & Weaknesses
Table 77. Nippon Fine Chemical Basic Information, Manufacturing Base and Competitors
Table 78. Nippon Fine Chemical Major Business
Table 79. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 80. Nippon Fine Chemical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Nippon Fine Chemical Recent Developments/Updates
Table 82. Nippon Fine Chemical Competitive Strengths & Weaknesses
Table 83. Croda International Basic Information, Manufacturing Base and Competitors
Table 84. Croda International Major Business
Table 85. Croda International Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 86. Croda International Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Croda International Recent Developments/Updates
Table 88. Croda International Competitive Strengths & Weaknesses
Table 89. ProBio Basic Information, Manufacturing Base and Competitors
Table 90. ProBio Major Business
Table 91. ProBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 92. ProBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. ProBio Recent Developments/Updates
Table 94. ProBio Competitive Strengths & Weaknesses
Table 95. Polymun Scientific Basic Information, Manufacturing Base and Competitors
Table 96. Polymun Scientific Major Business
Table 97. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 98. Polymun Scientific Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Polymun Scientific Recent Developments/Updates
Table 100. Polymun Scientific Competitive Strengths & Weaknesses
Table 101. Helix Biotech Basic Information, Manufacturing Base and Competitors
Table 102. Helix Biotech Major Business
Table 103. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 104. Helix Biotech Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. Helix Biotech Recent Developments/Updates
Table 106. Helix Biotech Competitive Strengths & Weaknesses
Table 107. Catalent Basic Information, Manufacturing Base and Competitors
Table 108. Catalent Major Business
Table 109. Catalent Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 110. Catalent Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Catalent Recent Developments/Updates
Table 112. Catalent Competitive Strengths & Weaknesses
Table 113. Porton Advanced Basic Information, Manufacturing Base and Competitors
Table 114. Porton Advanced Major Business
Table 115. Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 116. Porton Advanced Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Porton Advanced Recent Developments/Updates
Table 118. Porton Advanced Competitive Strengths & Weaknesses
Table 119. CATUG Basic Information, Manufacturing Base and Competitors
Table 120. CATUG Major Business
Table 121. CATUG Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 122. CATUG Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. CATUG Recent Developments/Updates
Table 124. CATUG Competitive Strengths & Weaknesses
Table 125. Samsung Biologics Basic Information, Manufacturing Base and Competitors
Table 126. Samsung Biologics Major Business
Table 127. Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 128. Samsung Biologics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Samsung Biologics Recent Developments/Updates
Table 130. Samsung Biologics Competitive Strengths & Weaknesses
Table 131. Biomay Basic Information, Manufacturing Base and Competitors
Table 132. Biomay Major Business
Table 133. Biomay Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 134. Biomay Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 135. Biomay Recent Developments/Updates
Table 136. Biomay Competitive Strengths & Weaknesses
Table 137. Pace Analytical Basic Information, Manufacturing Base and Competitors
Table 138. Pace Analytical Major Business
Table 139. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 140. Pace Analytical Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 141. Pace Analytical Recent Developments/Updates
Table 142. Pace Analytical Competitive Strengths & Weaknesses
Table 143. Vernal Biosciences Basic Information, Manufacturing Base and Competitors
Table 144. Vernal Biosciences Major Business
Table 145. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 146. Vernal Biosciences Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 147. Vernal Biosciences Recent Developments/Updates
Table 148. Vernal Biosciences Competitive Strengths & Weaknesses
Table 149. Lonza Basic Information, Manufacturing Base and Competitors
Table 150. Lonza Major Business
Table 151. Lonza Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 152. Lonza Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 153. Lonza Recent Developments/Updates
Table 154. Lonza Competitive Strengths & Weaknesses
Table 155. Acuitas Therapeutics Basic Information, Manufacturing Base and Competitors
Table 156. Acuitas Therapeutics Major Business
Table 157. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 158. Acuitas Therapeutics Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 159. Acuitas Therapeutics Recent Developments/Updates
Table 160. Acuitas Therapeutics Competitive Strengths & Weaknesses
Table 161. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 162. Creative Biolabs Major Business
Table 163. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 164. Creative Biolabs Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 165. Creative Biolabs Recent Developments/Updates
Table 166. Creative Biolabs Competitive Strengths & Weaknesses
Table 167. Curapath Basic Information, Manufacturing Base and Competitors
Table 168. Curapath Major Business
Table 169. Curapath Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 170. Curapath Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 171. Curapath Recent Developments/Updates
Table 172. Curapath Competitive Strengths & Weaknesses
Table 173. phosphorex Basic Information, Manufacturing Base and Competitors
Table 174. phosphorex Major Business
Table 175. phosphorex Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 176. phosphorex Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 177. phosphorex Recent Developments/Updates
Table 178. phosphorex Competitive Strengths & Weaknesses
Table 179. QiyueBio Basic Information, Manufacturing Base and Competitors
Table 180. QiyueBio Major Business
Table 181. QiyueBio Lipid Nanoparticle (LNP) CDMO Service Product and Services
Table 182. QiyueBio Lipid Nanoparticle (LNP) CDMO Service Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 183. QiyueBio Recent Developments/Updates
Table 184. QiyueBio Competitive Strengths & Weaknesses
Table 185. Global Key Players of Lipid Nanoparticle (LNP) CDMO Service Upstream (Raw Materials)
Table 186. Global Lipid Nanoparticle (LNP) CDMO Service Typical Customers
LIST OF FIGURES
Figure 1. Lipid Nanoparticle (LNP) CDMO Service Picture
Figure 2. World Lipid Nanoparticle (LNP) CDMO Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lipid Nanoparticle (LNP) CDMO Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 13. Lipid Nanoparticle (LNP) CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lipid Nanoparticle (LNP) CDMO Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lipid Nanoparticle (LNP) CDMO Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lipid Nanoparticle (LNP) CDMO Service Markets in 2025
Figure 27. United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type in 2025
Figure 31. Formulation Development
Figure 32. cGMP Manufacturing
Figure 33. Others
Figure 34. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type (2021-2032)
Figure 35. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type in 2025
Figure 37. mRNA-LNP CDMO Service
Figure 38. siRNA-LNP CDMO Service
Figure 39. Others
Figure 40. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type (2021-2032)
Figure 41. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 42. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale in 2025
Figure 43. Small-Scale Type: <1 L
Figure 44. Pilot / Clinical Type: 1–50 L
Figure 45. Commercial-Scale Type: >50 L
Figure 46. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale (2021-2032)
Figure 47. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application in 2025
Figure 49. Vaccine Development
Figure 50. Gene Therapy
Figure 51. Drug Delivery
Figure 52. Others
Figure 53. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application (2021-2032)
Figure 54. Lipid Nanoparticle (LNP) CDMO Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
Figure 1. Lipid Nanoparticle (LNP) CDMO Service Picture
Figure 2. World Lipid Nanoparticle (LNP) CDMO Service Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Lipid Nanoparticle (LNP) CDMO Service Total Revenue (2021-2032) & (USD Million)
Figure 4. World Lipid Nanoparticle (LNP) CDMO Service Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Lipid Nanoparticle (LNP) CDMO Service Revenue (2021-2032) & (USD Million)
Figure 13. Lipid Nanoparticle (LNP) CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 16. World Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 18. China Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 23. India Lipid Nanoparticle (LNP) CDMO Service Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Lipid Nanoparticle (LNP) CDMO Service by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Lipid Nanoparticle (LNP) CDMO Service Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Lipid Nanoparticle (LNP) CDMO Service Markets in 2025
Figure 27. United States VS China: Lipid Nanoparticle (LNP) CDMO Service Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Lipid Nanoparticle (LNP) CDMO Service Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type in 2025
Figure 31. Formulation Development
Figure 32. cGMP Manufacturing
Figure 33. Others
Figure 34. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Type (2021-2032)
Figure 35. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Nucleic Acid Type, (USD Million), 2021 & 2025 & 2032
Figure 36. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type in 2025
Figure 37. mRNA-LNP CDMO Service
Figure 38. siRNA-LNP CDMO Service
Figure 39. Others
Figure 40. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Nucleic Acid Type (2021-2032)
Figure 41. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Batch Scale, (USD Million), 2021 & 2025 & 2032
Figure 42. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale in 2025
Figure 43. Small-Scale Type: <1 L
Figure 44. Pilot / Clinical Type: 1–50 L
Figure 45. Commercial-Scale Type: >50 L
Figure 46. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Batch Scale (2021-2032)
Figure 47. World Lipid Nanoparticle (LNP) CDMO Service Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 48. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application in 2025
Figure 49. Vaccine Development
Figure 50. Gene Therapy
Figure 51. Drug Delivery
Figure 52. Others
Figure 53. World Lipid Nanoparticle (LNP) CDMO Service Market Size Market Share by Application (2021-2032)
Figure 54. Lipid Nanoparticle (LNP) CDMO Service Industrial Chain
Figure 55. Methodology
Figure 56. Research Process and Data Source
